ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Sinocelltech Group Limited clinical trials

Part of Lhasa Ailike Investment Consulting Co., Ltd., which holds 62.98% as of 2026-05-15. Source

The registry lists 81 studies whose lead sponsor is Sinocelltech Group Limited or one of 1 company grouped under it. 32 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 29, 2026.

Keep track of what changes. Save the Sinocelltech Group Limited studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Status unknown
35
Recruiting
16
Not yet recruiting
16
Completed
6
Active, not recruiting
3
Withdrawn
3

Phase

Phase 2
45
Phase 1
35
Phase 3
24
Phase 4
1

Where

China
49
United Arab Emirates
3
Turkey
2
Australia
1
Mexico
1
Argentina
1

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sinocelltech Group Limited.

  • Sinocelltech Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    81 studies →

Focus areas

Conditions Sinocelltech Group Limited leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

COVID-1922

Studies

Recruiting first, then most recently updated. Showing 50 of 81. Browse all 81 →